Japan's high-cost medical expense benefit system could be an obstacle to promoting generic imatinib
| Image |  |
|---|---|
| Description | scientific article published on 01 October 2019 |
| Author/s |
author: Hiroshi Ureshino |
| Publication date | October 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |